MENU
SUPN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Supernus Pharmaceuticals (SUPN) Earnings Date & Reports

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company... Show more

A.I. Advisor
published Earnings

SUPN is expected to report earnings to fall 167.33% to 68 cents per share on November 10

Supernus Pharmaceuticals SUPN Stock Earnings Reports
Q3'26
Est.
$0.68
Q2'26
Missed
by $1.44
Q1'26
Beat
by $0.41
Q4'25
Missed
by $0.48
Q3'25
Missed
by $0.94
The last earnings report on August 03 showed earnings per share of -100 cents, missing the estimate of 43 cents. With 274.85K shares outstanding, the current market capitalization sits at 2.60B.
View a ticker or compare two or three
SUPN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer for the treatment of central nervous system

Industry PharmaceuticalsGeneric

Industry
Pharmaceuticals Other
Address
9715 Key West Avenue
Phone
+1 301 838-2500
Employees
778
Web
https://www.supernus.com